Effects of a community-based physical exercise programme in patients with a combination of COPD and chronic heart failure: the CHEST-study
Completed
- Conditions
- COPDheart failure1001928010038716
- Registration Number
- NL-OMON33468
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
- Age between 40 and 75 years
- A clinical diagnosis of COPD defined by the GOLD-criteria stage 2 and 3
- A diagnosis of chronic heart failure defined by NYHA class II-III
- A left ventricular ejection fraction (LVEF) < 40% measured by
echocardiogram
- A history of smoking of at least 10 pack-years
Exclusion Criteria
- Serious other diseases with a survival rate of less than 1 year
- Other diseases which generate symptoms of dyspnoea and/or decreased
exercise capacity, or which seriously influence the ability to walk
- Participation in a pulmonary or cardiac rehabilitation programme less than
1 year ago
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure is exercise capacity measured with the 6 Minutes<br /><br>Walking Test, and daily activity rate, measured by pedometer.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcomes are: health-related quality of life (disease specific:<br /><br>Clinical COPD Questionnaire, Minnesota Living with Heart Failure Questionnaire,<br /><br>and generic: Euroqol 5D, SF-36), health-related behaviour (European Heart<br /><br>Failure Self-care Behaviour Scale) and self-efficacy (COPD Self-efficacy<br /><br>scale), and exercise capacity measured with the Incremental Shuttle Walk Test.</p><br>